3rd Great GI Debates

EBMed’s Great GI Debates will focus on: (a) inflammatory bowel disease; (b) esophageal disorders, including acid-peptic disorders and eosinophilic esophagitis; and (c) GI motility disorders, including irritable bowel syndrome and chronic idiopathic constipation; and (d) Impact of patient advocacy and artificial intelligence on practice of GI.  Interactive formats will be emphasized with minimal traditional lectures.

Target Audience

This activity is designed for an audience of Physicians, Nurse Practitioners, Physician Associates, as well as any other healthcare professionals interested in gastrointestinal diseases or disorders.

Learning Objectives

  • Describe evidence‑based management of esophageal–gastric and GI motility disorders, including GERD, EoE, H. pylori infection, gastroparesis, IBS, and the use of esophageal and anorectal manometry in evaluating motility disorders.
  • Apply effective strategies to teach early‑career GI trainees and GI‑APPs about AI applications in gastroenterology and their role in enhancing understanding of the patient experience.
  • Discuss evidence‑based management of inflammatory bowel disease—including Crohn’s disease, ulcerative colitis, and pouchitis—with emphasis on current clinical guidelines and emerging treatments.
Course summary
Available credit: 
  • 7.75 AANP
  • 7.75 AAPA Category 1 CME
  • 7.75 AMA PRA Category 1 Credit™
  • 7.75 Attendance
Course opens: 
02/08/2026
Course expires: 
03/08/2026
Cost:
$0.00
Rating: 
0
February 7-8, 2026 in Fort Lauderdale, FL
Westin Fort Lauderdale Beach Hotel
321 N. Fort Lauderdale Beach
Fort Lauderdale, FL
United States

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Committee Member, Planner, Staff(s)

Carol Antequera, DMSc, PA-C

has no relevant financial relationships to disclose at this time.

Dorothy Caputo, MA BSN RN

has no relevant financial relationships to disclose at this time.

Philip Schoenfeld, MD, MSEd, MSc (Epi)

has a financial relationship (Consultant) with Ardelyx;.
has a financial relationship (Consultant) with Ironwood;.
has a financial relationship (Speaker) with Ardelyx;.
has a financial relationship (Speaker) with Phathom;.
has a financial relationship (Consultant) with Phathom;.
has a financial relationship (Speaker) with Nestle;.

Norma Solis, DNP, APRN

has a financial relationship (Consultant) with Abbvie ;.
has a financial relationship (Speaker) with Pfizer ;.
has a financial relationship (Speaker) with Johnson & Johnson;.

Amber Tresca

has a financial relationship (Independent contractor (including contracted research)) with Johnson & Johnson;.
Course Director(s)

Philip Schoenfeld, MD, MSEd, MSc (Epi)

has a financial relationship (Consultant) with Ardelyx;.
has a financial relationship (Consultant) with Ironwood;.
has a financial relationship (Speaker) with Ardelyx;.
has a financial relationship (Speaker) with Phathom;.
has a financial relationship (Consultant) with Phathom;.
has a financial relationship (Speaker) with Nestle;.
Reviewer(s)

Bernadette Maker, MSN, APRN-BC, NP-C

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Bincy Abraham, MD, MS

has a financial relationship (Consultant) with Abbvie;.
has a financial relationship (Consultant) with Pfizer;.
has a financial relationship (Consultant) with Takeda;.
has a financial relationship (Consultant) with Johnson & Johnson;.
has a financial relationship (Consultant) with Lilly;.
has a financial relationship (Consultant) with Celltrion;.

Neena Abraham, MD, MSc (Epid), MACG, FASGE, AGAF

has no relevant financial relationships to disclose at this time.

Carol Antequera, DMSc, PA-C

has no relevant financial relationships to disclose at this time.

Darren Brenner, MD, FACG, AGAF, RFF

has a financial relationship (Consultant) with Alnylam;.
has a financial relationship (Consultant) with Salix ;.
has a financial relationship (Consultant) with Ardelyx ;.
has a financial relationship (Consultant) with Bayer;.
has a financial relationship (Consultant) with Abbive ;.
has a financial relationship (Consultant) with Ironwood ;.
has a financial relationship (Advisor) with Gemelli ;.
has a financial relationship (Consultant) with Laborie ;.
has a financial relationship (Consultant) with Vibrant ;.
has a financial relationship (Consultant) with Owlstone ;.
has a financial relationship (Consultant) with CinPhloro ;.
has a financial relationship (Consultant) with BioAmerica ;.
has a financial relationship (Consultant) with SidebyCare;.
has a financial relationship (Executive role) with IFFGD;.

Aline Charabaty Pishvaian

has a financial relationship (Advisor) with Abbvie , Eli Lilly, Janssen, Sanofi, Pfizer ;.

Jennifer Christie, Jennifer Christie, MD, MASGE, AGAF

has a financial relationship (Advisor) with Medscape;.
has a financial relationship (Researcher) with CINDome;.

Jalpa Devi, MBBS

has no relevant financial relationships to disclose at this time.

Paul Feuerstadt, MD, FACG, AGAF, FRCPE

has a financial relationship (Consultant) with Ferring Pharmaceuticals;.
has a financial relationship (Speaker) with Ferring Pharmaceuticals;.
has a financial relationship (Consultant) with Nestle Health Sciences;.
has a financial relationship (Speaker) with Nestle Health Sciences;.
has a financial relationship (Advisor) with Astrazenica;.
has a financial relationship (Consultant) with Sanofi/Regeneron;.
has a financial relationship (Speaker) with Sanofi/Regeneron;.

Gaylyn Henderson, MPH

has no relevant financial relationships to disclose at this time.

Carol Hernandez, Physician Associate

has a financial relationship (Speaker) with Johnson and Johnson;.
has a financial relationship (Speaker) with Abbvie;.
has a financial relationship (Speaker) with Phathom ;.

Kathryn Hutchins, MD

has no relevant financial relationships to disclose at this time.

Maia Kayal

has a financial relationship (Consultant) with Takeda ;.
has a financial relationship (Consultant) with Abbvie;.
has a financial relationship (Consultant) with Celltrion;.
has a financial relationship (Consultant) with Johnson&Johnson;.
has a financial relationship (Researcher) with Pfizer;.
has a financial relationship (Consultant) with Lily;.
has a financial relationship (Consultant) with Sanofi;.

Jami Kinnucan, MD, FACG, AGAF, FCCF

has a financial relationship (Advisor) with Abbvie;.
has a financial relationship (Advisor) with Pfizer;.
has a financial relationship (Advisor) with Lilly;.
has a financial relationship (Consultant) with Takeda;.
has a financial relationship (Executive role) with Gastro Digital Health;.
has a financial relationship (Executive role) with Florida Women's in GI;.
has a financial relationship (Advisor) with J&J;.

Jennifer Kolb, MD, MS

has a financial relationship (Speaker) with Castle Biosciences;.
has a financial relationship (Consultant) with Cook Medical;.
has a financial relationship (Consultant) with Neptune Medical;.
has a financial relationship (Researcher) with Exact Sciences;.

Lukasz Kwapisz, MD, FRCPC

has a financial relationship (Speaker) with AbbVie;.
has a financial relationship (Speaker) with J&J;.
has a financial relationship (Speaker) with Lilly;.
has a financial relationship (Speaker) with Celltrion;.
has a financial relationship (Speaker) with Pfizer;.
has a financial relationship (Advisor) with Ferring;.

Aja Mccutchen

has no relevant financial relationships to disclose at this time.

Mariam Naveed

has a financial relationship (Speaker) with Olympus;.

Linda Nguyen, MD

has a financial relationship (Consultant) with Ardelyx;.
has a financial relationship (Consultant) with Enterra Medical;.
has a financial relationship (Consultant) with AnX Robotic;.
has a financial relationship (Consultant) with Phathom;.
has a financial relationship (Consultant) with CinDome;.
has a financial relationship (Consultant) with Novo Nordisk;.
has a financial relationship (Consultant) with Eli Lilly;.

John Pandolfino, MD

has a financial relationship (Ownership interest) with Medtronic;.
has a financial relationship (Consultant) with Medtronic;.
has a financial relationship (Speaker) with Medtronic;.
has a financial relationship (Consultant) with Phathom;.
has a financial relationship (Speaker) with Phathom;.
has a financial relationship (Consultant) with Laborie;.
has a financial relationship (Ownership interest) with Laborie;.

Sandra Quezada, MD, MS, AGAF

has a financial relationship (Advisor) with Pfizer;.
has a financial relationship (Advisor) with Janssen;.
has a financial relationship (Advisor) with Lilly;.

Felice Schnoll-Sussman, MD MSc

has a financial relationship (Consultant) with Medtronic;.
has a financial relationship (Consultant) with Sebela;.

Philip Schoenfeld, MD, MSEd, MSc (Epi)

has a financial relationship (Consultant) with Ardelyx;.
has a financial relationship (Consultant) with Ironwood;.
has a financial relationship (Speaker) with Ardelyx;.
has a financial relationship (Speaker) with Phathom;.
has a financial relationship (Consultant) with Phathom;.
has a financial relationship (Speaker) with Nestle;.

Morgan Sendzischew Shane, MD MSCTI

has no relevant financial relationships to disclose at this time.

JOSEPH SLEIMAN, MD

has no relevant financial relationships to disclose at this time.

Norma Solis, DNP, APRN

has a financial relationship (Consultant) with Abbvie ;.
has a financial relationship (Speaker) with Pfizer ;.
has a financial relationship (Speaker) with Johnson & Johnson;.

Brennan Spiegel, MD, MSHS

has a financial relationship (Researcher) with Ardelyx;.
has a financial relationship (Researcher) with Ironwood;.

Amber Tresca

has a financial relationship (Independent contractor (including contracted research)) with Johnson & Johnson;.

Xiao Jing Wang, MD

has no relevant financial relationships to disclose at this time.

Rena Yadlapati, MD MS

has a financial relationship (Consultant) with Medtronid;.
has a financial relationship (Consultant) with Briantree Pharmaceuticals;.
has a financial relationship (Consultant) with Phathom Pharmaceuticals;.
has a financial relationship (Consultant) with Reckitt Benckiser Healthcare Ltd;.

 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and EBMed. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 7.75 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Designation Statement

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

Nurse Practitioners

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and EBMed. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 7.75 contact hour(s) (which includes   7.75 hour(s) of pharmacology).

 

Commercial Support

There is no commercial support for this activity.

 

 

 

 

Available Credit

  • 7.75 AANP
  • 7.75 AAPA Category 1 CME
  • 7.75 AMA PRA Category 1 Credit™
  • 7.75 Attendance

Price

Cost:
$0.00
Please login or register to take this course.